NEW YORK (AP) _ Rocket Pharmaceuticals Inc. (RCKT) on Wednesday reported a loss of $29.1 million in its third quarter.
On a per-share basis, the New York-based company said it had a loss of 53 cents.
The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 46 cents per share.
Rocket Pharmaceuticals shares have climbed 29% since the beginning of the year. The stock has more than doubled in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RCKT at https://www.zacks.com/ap/RCKT
Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News